NASDAQ: QUREUniqure Nv Stock Ownership - Who owns Uniqure Nv?
Insider buying vs selling
Have Uniqure Nv insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Christian Klemt | Chief Financial Officer | 2024-02-26 | 15,906 | $6.38 | $101.48kSell |
| Pierre Caloz | Chief Operating Officer | 2024-02-26 | 9,455 | $6.47 | $61.17kSell |
| Matthew C. Kapusta | CEO Managing Director | 2024-02-26 | 27,904 | $6.35 | $177.19kSell |
| Ricardo Dolmetsch | President RD | 2023-09-18 | 5,841 | $7.46 | $43.57kSell |
| Pierre Caloz | Chief Operating Officer | 2023-07-10 | 15,117 | $11.36 | $171.73kSell |
| Christian Klemt | Chief Financial Officer | 2023-06-16 | 1,587 | $18.94 | $30.06kSell |
| David D. Meek | Director | 2023-06-16 | 2,290 | $18.85 | $43.17kSell |
| Leonard E. Post | Director | 2023-06-16 | 2,291 | $18.83 | $43.14kSell |
| Paula Soteropoulos | Director | 2023-06-16 | 2,275 | $18.99 | $43.20kSell |
| Madhavan Balachandran | Director | 2023-06-16 | 2,283 | $18.91 | $43.17kSell |
QURE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when QURE insiders and whales buy or sell their stock.
QURE Shareholders
What type of owners hold Uniqure Nv stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Bv Foruniqure | 9.15% | 4,376,883 | $20.79M | Insider |
| Vestal Point Capital LP | 8.20% | 3,925,000 | $18.64M | Institution |
| State Street Corp | 7.27% | 3,478,872 | $16.52M | Institution |
| Nantahala Capital Management LLC | 6.18% | 2,958,027 | $14.05M | Institution |
| Blackrock Inc | 3.84% | 1,836,696 | $8.72M | Institution |
| Morgan Stanley | 3.68% | 1,759,818 | $8.36M | Institution |
| 683 Capital Management LLC | 3.54% | 1,693,000 | $8.04M | Institution |
| Orbimed Advisors LLC | 2.82% | 1,347,900 | $6.40M | Institution |
| Pictet Asset Management Holding Sa | 2.77% | 1,324,246 | $6.29M | Institution |
| Schroder Investment Management Group | 2.60% | 1,241,500 | $5.90M | Institution |
QURE vs Biotech Stocks
Uniqure Nv Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.